Can histological damage influence the severity of coeliac disease?. An unanswered question

Digestive and Liver Disease

Volumn 39, Issue 1, 2007, Pages 30-32

  Tursi, A ^a  

^a 'Lorenzo Bonomo' Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTAMIC ACID; GLYCINE; HEMOGLOBIN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ABDOMINAL PAIN; ARTICLE; CANCER; CELIAC DISEASE; CHROMOSOME 2; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIARRHEA; DISEASE CLASSIFICATION; DISEASE SEVERITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; IMMUNOPATHOGENESIS; INTESTINE ENDOSCOPY; INTESTINE VILLUS ATROPHY; NUTRITIONAL DEFICIENCY; OSTEOPENIA; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

EID: 33845863661     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.09.009     Document Type: Note

References (24)

1. Martucci S., Biagi F., Di Sabatino A., and Corazza G.R. Coeliac disease. Dig Liver Dis 94 Suppl. 2 (2002) S150-S153
2. Tursi A., Giorgetti G.M., Brandimarte G., Rubino E., Lombardi D., and Gasbarrini G. Prevalence and clinical presentation of subclinical/silent coeliac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology 39 (2001) 462-464
3. Ravikumara M., Tuthill D.P., and Jenkins H.R. The changing clinical presentation of celiac disease. Arch Dis Child (2006) [Epub ahead of print]
4. Rostami K., Kerckhaert J., Tiemessen R., von Blomberg M.E., Meijer J.W.R., and Mulder C.J.J. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94 (1999) 888-894
5. Dickey W., Hughes D.F., and McMillan S.A. Reliance on serum endomysium antibody testing underestimates the true prevalence of celiac disease by one fifth. Scand J Gastroenterol 35 (2000) 181-183
6. Tursi A., Brandimarte G., Giorgetti G., Gigliobianco A., Lombardi D., and Gasbarrini G. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent coeliac disease. Am J Gastroenterol 96 (2001) 1507-1510
7. Tursi A., Brandimarte G., Giorgetti G.M., and Gigliobianco A. Endoscopic features of coeliac disease in adults and its correlation with age, histological damage and clinical form of the disease. Endoscopy 34 (2002) 787-792
8. Tursi A., Brandimarte G., and Giorgetti G.M. Prevalence of anti-tissue transglutaminase in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 36 (2003) 219-221
9. Brar P., Kwon G.Y., Egbuna I.I., Holleran S., Ramakrishnan R., Bhagat G., et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis (2007)
10. Tursi A., and Brandimarte G. The symptomatic and histologic response to a gluten-free diet in patients with borderline enteropathy. J Clin Gastroenterol 36 (2003) 13-17
11. Sbarbati A., Valletta E., Bertini M., Cipolli M., Morroni M., Pinelli L., et al. Gluten sensitivity and 'normal' histology: is the intestinal mucosa really normal?. Dig Liver Dis 35 (2003) 768-773
12. Viljamaa M., Kaukinen K., Pukkala E., Hervonen K., Regnala T., and Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: a 30-year population-based study. Dig Liver Dis 38 (2006) 374-380
13. Usai P., Minerba L., Marini B., Cossu R., Spada S., Carpinello B., et al. Case control study on health-related quality of life in adult coeliac disease. Dig Liver Dis 34 (2002) 547-552
14. Salmi T.T., Collin P., Korponay-Szabo I.R., Laurila K., Partanen J., Huhtala H., et al. Endomysial antibody-negative celiac disease: clinical characteristics and intestinal autoantibody deposits. Gut 55 (2006) 1746-1753
15. Mustalahti K., Holopainen P., Karell K., Mäki M., and Partanen J. Genetic dissection between silent and clinically diagnosed symptomatic forms of coeliac disease in multiplex families. Dig Liver Dis 34 (2002) 842-845
16. *0201 allele contributes to severity of coeliac disease. Scand J Gastroenterol 41 (2006) 191-199
17. Mora B., Bonamico M., Indovina P., Megiorni F., Ferri M., Carbone M.C., et al. CTLA-4 +49 A/G dimorphism in Italian patients with celiac disease. Hum Immunol 64 (2003) 297-301
18. Martin-Pagola A., Perez de Nanclares G., Vitoria J.C., Bilbao J.R., Ortiz L., Zubillaga P., et al. No association of CTLA4 gene with celiac disease in the Basque population. J Pediatr Gastroenterol Nutr 37 (2003) 142-145
19. Danese S., Semeraro S., Marini M., Roberto I., Armuzzi A., Papa A., et al. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Dig Liver Dis 37 (2005) 811-818
20. Abel M., Cellier C., Kumar N., Cerf-Bensussan N., Schmitz J., and Caillat-Zucman S. Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum Immunol 67 (2006) 612-617
21. Lopez-Vazquez A., Rodrigo L., Fuentes D., Rientra S., Bousono C., Garcia-Fernandez S., et al. MICA-A5.1 allele is associated with atypical forms of celiac disease in HLA-DQ2-negative patients. Immunogenetics 53 (2002) 989-991
22. Lopez-Vazquez A., Fuentes D., Rodrigo L., Gonzales S., Moreno M., Fernandez E., et al. MHC class I region plays a role in the development of diverse clinical forms of celiac disease in a Saharawi population. Am J Gastroenterol 99 (2004) 662-667
23. Ventura A., Magazzù G., and Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 117 (1999) 297-303
24. Londei M. The external world of gluten and autoimmunity. Gut 49 (2001) 463-464